There really is a quiet arithmetic we seem to forget whenever we speak about financing health, and that is, “money not spent is money saved”. It sounds almost too simple to be taken seriously in policy circles, yet it is perhaps a foundational principle of any sustainable system, economic or otherwise.
In recent years, the conversation around health financing has become so popular yet increasingly narrow, that whenever it’s being discussed, the theme of bigger budgets, expanded insurance schemes, increased donor flows, and new funding mechanisms is the only thing in lens. Though all of these are unarguably important, they are only one side of the equation, as financing health is not merely about how much money enters the system, but also about how much unnecessary expenditure we can prevent from ever occurring. And this is where preventive health quietly stands as one of the most underutilized financing strategies.
Often preached, prevention is prevalently taken as some moral or clinical responsibility, something good to do for public health, but not worth framing as a fiscal strategy. Yet, at its core, prevention is economic discipline.
I don’t think it should be difficult to interpret that a well-prevented illness is not just a life improved; it is a cost avoided, a drug regimen that was never needed, and in many cases, a financial burden that never fell on a household.
